Table 2 Differences in variables at the start of the study in experimental and control group.
TOTAL | CONTROL | EXPERIMENTAL | |
|---|---|---|---|
Gender (M/F) | 26 (50%)/ 26 (50%) | 11 (44.5%)/ 14 (55.6%) | 15 (56%)/ 12 (44%) |
BMI (kg/m2) | 26.6 (4.0) | 26.9 (4.6) | 26.3 (3.3) |
Calf Circunference (cm) | 33.0 (4.2) | 32.9 (4.4) | 33.1 (4.2) |
SGA (A/B/C) | 28 (53.8%)/13 (25%)/10 (19.2%) | 12 (48.1%)/ 7 (25.9%)/ 6 (22.2%) | 16 (60%)/6 (24%)/5 (16%) |
Age (years) | 77.4 (11.5) | 78.9 (9.7) | 75.9 (13.2) |
RANKIN scale | 0 (0–2) | 0 (0–0) | 0 (0–2.5) |
NIHSS | 17.6 (6.4) | 16.9 (7.1) | 18.3 (5.6) |
Glomerullar Filtration (ml/min) | 84.7 (29.7) | 84.2 (35.9) | 85.2 (22.2) |
Na (mg/dL)* | 142.9 (3.9) | 144.1 (3.4) | 141.7 (4.2) |
K (mg/dL) | 4.0 (0.4) | 3.9 (0.5) | 4.1 (0.4) |
Plasma Insulin (mg/dL) | 15.5 (11.7) | 14.2 (7.1) | 16.6 (14.7) |
HbA1c (%) | 5.6 (0.4) | 5.6 (0.4) | 5.6 (0.4) |
Glycaemia (mg/dL) | 113.7 (21.8) | 115.7 (22.5) | 111.5 (21.3) |
Total Cholesterol (mg/dL) | 167.8 (38.8) | 174.1 (41.0) | 160.8 (35.7) |
Triglycerides (mg/dL) | 98.6 (33.8) | 101.7 (38.4) | 95.2 (28.4) |
Length of stay (days) | 15.0 (11.1) | 12 (7–30) | 14 (7–30) |
Stroke type (Ischaemic/hemorragic)* | 34 (65.4%)/18 (34.6%) | 13 (51.9%)/12 (48.1%) | 22 (80%)/ 5 (20%) |
